è
«çåŠãã€ãªå»è¬åäŒæ¥ã§ãã Veru Inc. ã¯ãããã®ç®¡çã®ããã®å»è¬åã®éçºã«éç¹ã眮ããŠããŸããå瀟ã®åžè²©è£œåã«ã¯ãä¿å¥çãæ¿åºä¿å¥æ©é¢ãåœé£æ©é¢ãéå¶å©å£äœã忥ããŒãããŒåãã®ãæãŸãªãåŠåš ãšæ§ææçã®ææã«å¯Ÿããäºéã®äºé²ãç®çãšãã FC2 女æ§çšã³ã³ããŒã /äœå
ã³ã³ããŒã ããããŸããå瀟ã®éçºåè£è¬ã«ã¯ãAR+ ER+ HER2-転移æ§ä¹³ããã®æ²»çè¬ãšããŠç¬¬ III çžèšåºè©Šéšäžã®çµå£éžæçã¢ã³ããã²ã³å容äœäœåè¬ã§ãããšãããµã«ã ãAR+ ER+ HER2-転移æ§ä¹³ããã®æ²»çè¬ãšããŠç¬¬ IIb çžèšåºè©Šéšäžã®ãµãã¶ããªã³ãAR+ ER+ HER2-転移æ§ä¹³ããã®æ²»çè¬ãšããŠç¬¬ III çžèšåºè©Šéšäžã®ãšãããµã«ã + ã¢ããã·ã¯ãªã䜵çšçæ³ããããŸãããŸãã転移æ§ããªãã«ãã¬ãã£ãä¹³ããã®æ²»çè¬ãšããŠç¬¬IIçžèšåºè©Šéšãè¡ãããŠããçµå£æšç现èéªšæ Œç Žå£è¬ãšéžæçã¢ã³ããã²ã³å容äœäœåè¬ã§ãããµãã¶ããªã³ïŒãšãããµã«ã ã®äœµçšçæ³ãéçºäžã§ãããå瀟ã®åè£è¬ã«ã¯ã転移æ§å»å¢ããã³ã¢ã³ããã²ã³åå®¹äœæšçè¬æµææ§åç«è
ºããã®æ²»çè¬ãšããŠç¬¬IIçžèšåºè©Šéšãè¡ãããŠãããµãã¶ããªã³ãé²è¡æ§ãã«ã¢ã³æåæ§åç«è
ºããã®æ²»çè¬ãšããŠç¬¬IIçžèšåºè©Šéšãè¡ãããŠããGnRHæ®æè¬ããããæ³šå°å€VERU-100ãã»ãŠãã®æ²»çè¬ãšããŠç¬¬IIçžèšåºè©Šéšãè¡ãããŠããã¯ãšã³é
žãºã¯ãããã§ã³ãæ¥æ§åŒåžçª®è¿«çå矀ã®ãªã¹ã¯ãé«ã被éšè
ã«ãããSARS-CoV-2ã®æ²»çè¬ãšããŠç¬¬IIIçžèšåºè©Šéšãè¡ãããŠãããµãã¶ããªã³ãå«ãŸãããããã«ãå瀟ã¯åç«è
ºè¥å€§çã«ããäžéšå°¿è·¯çç¶ãåããç·æ§ã®æ²»çè¬ãšããŠãæ°ããªè¬å€åŠæ¹ã®éçºãé²ããŠãããå瀟ã¯ä»¥åã¯The Female Health CompanyãšããŠç¥ãããŠããŸãããã2017幎7æã«Veru Inc.ã«ç€Ÿåã倿ŽããŸãããVeru Inc.ã¯1971幎ã«èšç«ããããããªãå·ãã€ã¢ãã«æ¬ç€Ÿã眮ããŠããŸãã